Cure My Disease

Don't miss your cure!

 Log in / Sign up

Battle of the surgical scrubs: which cleaner wins?

NCT ID NCT00799812

Disease control Sponsor: C. R. Bard Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different ways to clean the skin before surgery to reduce germs. It compared ChloraPrep (applied all at once or one at a time) with Hibiclens and plain water. 335 healthy adults took part, and the goal was to see which method lowered bacteria the most after 10 minutes and 6 hours.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

335 people

The number who actually took part.

Started

Nov 2007

Finished

Jun 2008

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

16 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects must read and sign an Informed Consent Form and be cooperative. * Subjects must be in good general health. * Subjects must have skin within 6 inches of the test site that is free of tattoos, dermatoses, abrasions, cuts, lesions, or other skin disorders. Exclusion Criteria: * Use of systemic or topical antimicrobials during the 2-week pretest conditioning period. This restriction includes but is not limited to shampoos, lotions, soaps, baby powders, and materials, such as solvents, acids, or alkalis. * A medical diagnosis of a physical condition, which would preclude participation such as: diabetes, hepatitis, an organ transplant, a medical surgical implant, or an immunocompromised system. * Any medical condition that in the opinion of the investigator would preclude participation. * Bathed in chemically treated pools or hot tubs 2 weeks prior to any microbial sampling. * Used UV tanning lamps 2 weeks prior to any microbial sampling. * Bathing or showering less than 48 hours prior to any microbial sampling. * Known sensitivity to chlorhexidine gluconate. * Known sensitivity to latex (rubber). * Known sensitivity to fragrances. * Pregnant or nursing. * Unwillingness to fulfill the performance requirements of the study. * Subjects who have completed part or all of the study will not be reentered in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Topical antisepsis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Topical antisepsis

Contacts and locations

Locations

  • Microbiotest

    Sterling, Virginia, 20164, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.